|
|
||||||||
The Journal of Immunology, Vol 157, Issue 10 4421-4427, Copyright © 1996 by American Association of Immunologists
ARTICLES |
T von der Weid, AM Beebe, DC Roopenian and RL Coffman
Department of Immunology, DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA 94304, USA.
Splenic CD4+NK1.1+ T cells have been shown to secrete large and transient amounts of IL-4 mRNA 90 min after i.v. injection of anti-CD3 Ab, suggesting that this novel subset of T cells may induce Th2 responses in the spleen by quickly providing IL-4 at the onset of an immune response. beta2-microglobulin-deficient (beta2m(o/o)) mice have been shown to contain strongly reduced numbers of NK1.1+ T cells and to be severely impaired in their capacity for rapid induction of IL-4 mRNA in response to anti-CD3, demonstrating that these cells are MHC class I dependent. To address the role of CD4+NK1.1+ T cells in the induction of Th2 responses against Leishmania major, we have dissected the onset and the outcome of the immune response elicited against the parasite in BALB/c-beta2m(o/o) mice and in anti-NK1.1-treated congenic BALB/c mice expressing the NK1.1 marker (BALB/c-NK1.1+). Both BALB/c-beta2m(o/o) and NK1.1-depleted BALB/c-NK1.1+ mice developed a progressive, nonhealing disease that was indistinguishable from wild-type mice. Upon infection, early induction of IL-4 mRNA in the lymph node was not affected in BALB/c-beta2m(o/o) and in NK1.1-depleted BALB/c-NK1.1+ mice, but was abrogated by injection of a CD4-depleting Ab. These data suggest that, in the lymph node, MHC class I-dependent CD4+NK1.1+ T cells do not play a major role in the generation of Th2 responses against L. major. To investigate whether the inability of NK1.1+ T cells to induce IL-4 production in the lymph node was specific to L. major Ag, mice were challenged with low doses of anti-CD3 Ab s.c. in the footpad. In contrast to the spleen, normal levels of IL-4 mRNA were expressed in the lymph nodes of BALB/c-beta2m(o/o) mice. Thus, the MHC class I-dependent CD4+NK1.1+ cell population that gives a rapid IL-4 response in the spleen appears not to contribute significantly to early induced IL-4 responses in the popliteal lymph nodes.
This article has been cited by other articles:
![]() |
N. Mikhalkevich, B. Becknell, M. A. Caligiuri, M. D. Bates, R. Harvey, and W.-p. Zheng Responsiveness of Naive CD4 T Cells to Polarizing Cytokine Determines the Ratio of Th1 and Th2 Cell Differentiation J. Immunol., February 1, 2006; 176(3): 1553 - 1560. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Cunningham, P. G. Fallon, M. Khan, S. Vacheron, H. Acha-Orbea, I. C. M. MacLennan, A. N. McKenzie, and K.-M. Toellner Th2 Activities Induced During Virgin T Cell Priming in the Absence of IL-4, IL-13, and B Cells J. Immunol., September 15, 2002; 169(6): 2900 - 2906. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Hurst, T. Muchamuel, D. M. Gorman, J. M. Gilbert, T. Clifford, S. Kwan, S. Menon, B. Seymour, C. Jackson, T. T. Kung, et al. New IL-17 Family Members Promote Th1 or Th2 Responses in the Lung: In Vivo Function of the Novel Cytokine IL-25 J. Immunol., July 1, 2002; 169(1): 443 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Launois, A. Gumy, H. Himmelrich, R. M. Locksley, M. Rocken, and J. A. Louis Rapid IL-4 Production by Leishmania Homolog of Mammalian RACK1-Reactive CD4+ T Cells in Resistant Mice Treated Once with Anti-IL-12 or -IFN-{gamma} Antibodies at the Onset of Infection with Leishmania major Instructs Th2 Cell Development, Resulting in Nonhealing Lesions J. Immunol., May 1, 2002; 168(9): 4628 - 4635. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Almeida, R. M. Andrade, and C. A. M. Bento The Capsular Polysaccharides of Cryptococcus neoformans Activate Normal CD4+ T Cells in a Dominant Th2 Pattern J. Immunol., November 15, 2001; 167(10): 5845 - 5851. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Das, S. Sheridan, and C. A. Janeway Jr. The Source of Early IFN-{gamma} That Plays a Role in Th1 Priming J. Immunol., August 15, 2001; 167(4): 2004 - 2010. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. L. Hammond, D. G. Pellicci, L. D. Poulton, O. V. Naidenko, A. A. Scalzo, A. G. Baxter, and D. I. Godfrey CD1d-Restricted NKT Cells: An Interstrain Comparison J. Immunol., August 1, 2001; 167(3): 1164 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Z. Tau, T. von der Weid, B. Lu, S. Cowan, M. Kvatyuk, A. Pernis, G. Cattoretti, N. S. Braunstein, R. L. Coffman, and P. B. Rothman Interferon {gamma} Signaling Alters the Function of T Helper Type 1 Cells J. Exp. Med., October 2, 2000; 192(7): 977 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Garn, A. Friedetzky, A. Kirchner, R. Jager, and D. Gemsa Experimental silicosis: a shift to a preferential IFN-gamma -based Th1 response in thoracic lymph nodes Am J Physiol Lung Cell Mol Physiol, June 1, 2000; 278(6): L1221 - L1230. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Finkelman, S. C. Morris, T. Orekhova, M. Mori, D. Donaldson, S. L. Reiner, N. L. Reilly, L. Schopf, and J. F. Urban Jr. Stat6 Regulation of In Vivo IL-4 Responses J. Immunol., March 1, 2000; 164(5): 2303 - 2310. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-T. Chen, F.-L. Chen, and J. T. Kung Age-Associated Rapid and Stat6-Independent IL-4 Production by NK1-CD4+8- Thymus T Lymphocytes J. Immunol., November 1, 1999; 163(9): 4747 - 4753. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Singh, S. Hong, D. C. Scherer, I. Serizawa, N. Burdin, M. Kronenberg, Y. Koezuka, and L. Van Kaer Cutting Edge: Activation of NK T Cells by CD1d and {alpha}-Galactosylceramide Directs Conventional T Cells to the Acquisition of a Th2 Phenotype J. Immunol., September 1, 1999; 163(5): 2373 - 2377. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. George, J. R. Ortaldo, S. Lemieux, V. Kumar, and M. Bennett Tolerance and Alloreactivity of the Ly49D Subset of Murine NK Cells J. Immunol., August 15, 1999; 163(4): 1859 - 1867. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Moodycliffe, S. Maiti, and S. E. Ullrich Splenic NK1.1-Negative, TCR{alpha}{beta} Intermediate CD4+ T Cells Exist in Naive NK1.1 Allelic Positive and Negative Mice, with the Capacity to Rapidly Secrete Large Amounts of IL-4 and IFN-{gamma} Upon Primary TCR Stimulation J. Immunol., May 1, 1999; 162(9): 5156 - 5163. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Dent, J. Hu-Li, W. E. Paul, and L. M. Staudt T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6 PNAS, November 10, 1998; 95(23): 13823 - 13828. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Huber, E. Timms, T. W. Mak, M. Rollinghoff, and M. Lohoff Effective and Long-Lasting Immunity against the Parasite Leishmania major in CD8-Deficient Mice Infect. Immun., August 1, 1998; 66(8): 3968 - 3970. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Flynn, K.-M. Toellner, C. Raykundalia, M. Goodall, and P. Lane CD4 T Cell Cytokine Differentiation: The B Cell Activation Molecule, OX40 Ligand, Instructs CD4 T Cells to Express Interleukin 4 and Upregulates Expression of the Chemokine Receptor, Blr-1 J. Exp. Med., July 20, 1998; 188(2): 297 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Morris, R. L. Coffman, and F. D. Finkelman In Vivo IL-4 Responses to Anti-IgD Antibody Are MHC Class II Dependent and {beta}2-Microglobulin Independent and Develop Normally in the Absence of IL-4 Priming of T Cells J. Immunol., April 1, 1998; 160(7): 3299 - 3304. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Ortaldo, R. Winkler-Pickett, A. T. Mason, and L. H. Mason The Ly-49 Family: Regulation of Cytotoxicity and Cytokine Production in Murine CD3+ Cells J. Immunol., February 1, 1998; 160(3): 1158 - 1165. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Noben-Trauth, L. D. Shultz, F. Brombacher, J. F. Urban Jr., H. Gu, and W. E. Paul An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice PNAS, September 30, 1997; 94(20): 10838 - 10843. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Coffman and T. Weid Multiple Pathways for the Initiation of T Helper 2 (Th2) Responses J. Exp. Med., February 3, 1997; 185(3): 373 - 376. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |